Peptide Side Effects: What's Normal and What to Report

Three days into a new injection, your stomach is off and there's a pink welt where the needle went in. Is that normal? Should you call someone tonight, mention it at your next check-in, or stop? Most peptide websites skip this part. This one is about exactly that: which reactions are expected, which ones need a prompt call, and which ones mean emergency care.

Nothing here replaces the instructions from your own prescriber and pharmacy label. Use it as a framework for recognizing what matters, and keep your clinic's contact details somewhere you can find them at 2 a.m.

Why side effects vary so much between peptides

"Peptide" describes a type of molecule, not a type of effect. Insulin, semaglutide, bremelanotide and BPC-157 are all peptides, and they do completely different things in the body. So there is no single list of peptide side effects. There are a few patterns worth understanding, though.

• Effects from what the drug does. A GLP-1 medicine slows stomach emptying, so nausea is expected. A growth hormone-releasing drug can cause fluid retention. These follow from the mechanism.
• Effects from how it is given. Most peptides are injected under the skin, so local reactions are common across many of them.
• Immune reactions to the molecule. Peptides can provoke an immune response, called immunogenicity. FDA has specifically flagged this risk, along with aggregation and peptide-related impurities, for several compounded peptides it reviewed.
• Effects from the product, not the peptide. Contamination, wrong concentration, or the wrong substance entirely. This is the main danger with products outside the pharmacy system.

Common side effects: what approved peptide labels show

FDA-approved peptide medicines have labeling based on clinical trials, which gives us a real picture of what is common. A few examples:

• Semaglutide (Wegovy). The most common reactions listed include nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue and dizziness. Warnings cover acute pancreatitis, gallbladder disease, low blood sugar, kidney injury from dehydration, allergic reactions, heart rate increase, and suicidal behavior and ideation, among others.
• Bremelanotide (Vyleesi). Its labeling reports nausea in about 40% of patients in trials, along with flushing, injection-site reactions, headache and vomiting. It can cause a transient rise in blood pressure, and focal darkening of the skin was reported in about 1% of patients.
• Tesamorelin (Egrifta). Labeling lists joint pain, injection-site redness and itching, limb pain, swelling and muscle pain as common. Injection-site reactions occurred in about a quarter of treated patients, and hypersensitivity reactions in about 4%. Warnings include glucose intolerance and fluid retention.

The takeaway is not the specific percentages. It is that approved drugs come with a known, published profile you and your clinician can plan around. Most unapproved peptides do not. For more on that difference, see the peptide medicines that are FDA-approved, and for GLP-1s specifically, managing GLP-1 side effects.

Injection-site reactions: normal vs not

Small, local reactions are among the most frequent complaints with injected peptides. Here is a practical way to tell them apart.

Rotating sites and following your pharmacy's technique instructions reduce many local problems. Our guide on how to give a subcutaneous injection covers the basics for a medication your clinician prescribed.

When to call 911 or go to the emergency room

These can signal a severe allergic reaction or another emergency. Don't drive yourself.

• Trouble breathing, wheezing, or a tight throat
• Swelling of the face, lips, tongue or throat
• Widespread hives with dizziness, fainting, or a racing heartbeat
• Chest pain or pressure, or sudden severe headache
• Confusion, seizure, or loss of consciousness
• Signs of very low blood sugar that don't improve quickly, especially if you also take insulin or a sulfonylurea

If you think you've taken too much, or injected the wrong amount, call Poison Control at 1-800-222-1222 for guidance, and call 911 if you have serious symptoms.

When to contact your prescriber the same day

• Severe or persistent abdominal pain, especially pain that spreads to your back, with or without vomiting. With GLP-1 medicines this can be a sign of pancreatitis or gallbladder disease.
• Vomiting or diarrhea that stops you keeping fluids down, or signs of dehydration such as very little urine.
• New swelling in your hands, feet or ankles, or numbness and tingling in the hands.
• A lump or swelling in the neck, trouble swallowing or persistent hoarseness if you take a GLP-1 medicine.
• Vision changes.
• Mood changes, new anxiety, depression, or thoughts of self-harm. If you are in crisis, call or text 988.
• A fever or an injection site that looks infected.

What to mention at your next check-in

Not everything needs a same-day call. Keep notes on milder effects so your clinician can see the pattern:

• Mild nausea, reduced appetite, constipation or reflux
• Headaches, fatigue or sleep changes
• Small, short-lived injection-site reactions
• Flushing or mild dizziness
• Any change in how you feel that you can't explain

Write down the date, the dose you took, the time, what you noticed and how long it lasted. That record is far more useful than "I felt off last week."

How to report a side effect

1. Tell your prescriber. They can decide whether to adjust, pause or stop treatment, and document the reaction in your record.
2. Tell the dispensing pharmacy. Pharmacies track product problems, and a pattern across patients can reveal a bad batch.
3. Report to FDA through MedWatch. Patients can submit reports directly, online or by phone at 1-800-FDA-1088. Reports help FDA spot safety signals, including with compounded products. FDA's MedWatch page has the forms.
4. Keep the product. If you suspect a product problem, keep the vial or pen and its packaging, and note the lot number.

The extra risk with unapproved and grey-market peptides

With an approved medicine, a side effect can be checked against labeling built from thousands of trial participants. With an unapproved peptide, there is no such reference. FDA reviewers who looked at BPC-157 described its human studies as short, small and insufficient to establish safety or effectiveness. Several other popular peptides have even less human data.

That means you and your clinician are working partly blind: you can't always tell whether a symptom is a known effect, a rare one, or a sign the product isn't what it claims to be. It's a key reason supervised care matters. Our overview of who should not use peptide therapy covers the people for whom this uncertainty is hardest to justify.

What good follow-up looks like

A responsible peptide service tells you, before you start, which side effects to expect, which ones to report, and how to reach someone. It orders baseline labs where relevant and rechecks them. It names the pharmacy. And it is willing to stop a treatment that isn't working or isn't tolerated, rather than adding another product on top.

That's how our peptide therapy consultations are structured. If you've been having side effects from something prescribed elsewhere, or bought online, and want an honest second opinion, book a consultation. We may recommend stopping, and we may recommend an in-person evaluation instead.

Common questions

Are peptide injection side effects usually serious?

Most reported side effects of approved peptide medicines are mild to moderate, such as nausea or injection-site redness. Serious reactions do occur, which is why knowing the warning signs matters. For unapproved peptides, the side-effect profile simply hasn't been established.

Should I stop my peptide if I get side effects?

For emergency symptoms, get help first. For anything else, contact your prescriber before stopping, since some medicines need a plan, and your prescriber may adjust rather than stop.

Can I report a side effect from a compounded peptide to FDA?

Yes. MedWatch accepts reports about compounded products, and it helps to include the pharmacy name and lot number.

Why did I get a reaction after weeks without problems?

Immune reactions can develop with repeated exposure, a new batch can differ, and injection technique can drift. Tell your prescriber; don't assume it's nothing because earlier doses were fine.